These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 990706)

  • 1. Scanning electron microscopy of normal human scar tissue and keloids.
    Hunter JA; Finlay JB
    Br J Surg; 1976 Oct; 63(10):826-30. PubMed ID: 990706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the collagen nodule from hypertrophic scars and keloids.
    Kischer CW; Brody GS
    Scan Electron Microsc; 1981; (Pt 3):371-6. PubMed ID: 7330586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic scars and keloids: a review and new concept concerning their origin.
    Kischer CW; Shetlar MR; Chvapil M
    Scan Electron Microsc; 1982; (Pt 4):1699-713. PubMed ID: 7184146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A wound contraction experimental model for studying keloids and wound-healing modulators.
    Kamamoto F; Paggiaro AO; Rodas A; Herson MR; Mathor MB; Ferreira MC
    Artif Organs; 2003 Aug; 27(8):701-5. PubMed ID: 12911344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D modeling of keloid scars in vitro by cell and tissue engineering.
    Suttho D; Mankhetkorn S; Binda D; Pazart L; Humbert P; Rolin G
    Arch Dermatol Res; 2017 Jan; 309(1):55-62. PubMed ID: 27942931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure of keloid: an unusual incident involving lepromatous leprosy.
    Dyer RF; Enna CD
    Int J Dermatol; 1975 Dec; 14(10):743-54. PubMed ID: 1201885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative ultrastructure of hypertrophic scars and keloids.
    Kischer CW
    Scan Electron Microsc; 1984; (Pt 1):423-31. PubMed ID: 6740239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic scar and keloid. I. Etiology, pathogenesis, pathology].
    Salamon A
    Morphol Igazsagugyi Orv Sz; 1984 Oct; 24(4):262-7. PubMed ID: 6513952
    [No Abstract]   [Full Text] [Related]  

  • 9. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids.
    Kischer CW; Thies AC; Chvapil M
    Hum Pathol; 1982 Sep; 13(9):819-24. PubMed ID: 7106747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
    Bux S; Madaree A
    Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars.
    Ghazizadeh M; Miyata N; Sasaki Y; Arai K; Aihara K
    Am J Dermatopathol; 1997 Oct; 19(5):468-72. PubMed ID: 9335240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblasts of the hypertrophic scar, mature scar and normal skin: A study by scanning and transmission electron microscopy.
    Kischer CW
    Tex Rep Biol Med; 1974; 32(3-4):699-709. PubMed ID: 4460249
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immunochemical differences between keloid and hypertrophic scar.
    Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G
    Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibroblasts in head and neck surgery. An experimental and clinical study.
    Larrabee WF; Bolen JW; Sutton D
    Arch Otolaryngol Head Neck Surg; 1988 Sep; 114(9):982-6. PubMed ID: 3044394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
    Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
    Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.